Improving early detection of Alzheimer's disease in African American communities
Brain CHEC-AC (Brain and Cognitive Health Equity Campaign for Allegheny County)
This study is looking to help African American adults by finding and fixing the barriers that make it harder for them to get diagnosed with Alzheimer's and related dementias, so they can receive the right treatment sooner.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11060195 on NIH RePORTER |
What this research studies
This research focuses on addressing the significant disparities in the diagnosis of Alzheimer's disease and related dementias (ADRD) among African American adults. It aims to identify and dismantle structural barriers that contribute to these disparities, such as societal stigma and discrimination in medical settings. By implementing multilevel interventions, the project seeks to improve early detection and diagnosis of ADRD, ensuring that affected individuals receive timely treatment. The research will also explore the impact of newly available disease-modifying therapies that require early diagnosis for effective administration.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American adults aged 21 and older who may be at risk for Alzheimer's disease or related dementias.
Not a fit: Patients who are not African American or those who do not have concerns about Alzheimer's disease or related dementias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and treatment of Alzheimer's disease for African American patients, improving their health outcomes.
How similar studies have performed: Previous research has shown success in addressing health disparities through targeted interventions, indicating that this approach has potential for positive outcomes.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Lingler, Jennifer Hagerty — University of Pittsburgh at Pittsburgh
- Study coordinator: Lingler, Jennifer Hagerty
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.